RMC-4998 is an orally available KRASG12C mutant inhibitor that targets the active or GTP-bound state of the KRASG12C mutant and binds to intracellular CYPA to form a triple complex to inhibit the ERK signaling pathway and induce apoptosis, which is of great significance for tumor research.
Molekulargewicht:
983.25
Reinheit:
99.11%
CAS Nummer:
[2642037-07-6]
Formel:
C57H74N8O7
Target-Kategorie:
Apoptosis|||ERK|||mTOR|||PI3K|||Ras|||Kras
T79870
T79870
T79870
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten